Schizophrenia: long-acting aripiprazole forms have similar efficacy

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Takeaway

  • An indirect comparison between aripiprazole lauroxil (AL; Aristada) once-monthly vs aripiprazole once-monthly (AOM) long-acting injectable revealed similar efficacy and side-effect profiles.
  • Only 1 dose, AOM 400 mg, was associated with statistically significant weight gain vs pla...